Scientists from the German Center for Infection Research (DZIF) and the Justus Liebig University Giessen (JLU) have evaluated a rapid test that detects the dreaded colistin resistance gene within twenty minutes. It can therefore ...
Feb 6, 2017
0
0
Research presented at the 2015 AACC Annual Meeting & Clinical Lab Expo will expand on the studies that led to a fingerprick Ebola test becoming the first and only rapid diagnostic for this disease to receive approval from ...
Jul 29, 2015
0
28
Malaria elimination is possible within a generation. But controlling malaria and eliminating malaria are different, and each pose certain challenges. Overcoming the unique challenges of malaria elimination is essential to ...
Jun 22, 2015
0
8
University of Texas Medical Branch researchers who helped assess the effectiveness of a new rapid test kit to diagnose Ebola learned this week it has received emergency use authorization from the Food and Drug Administration.
Mar 4, 2015
0
5
The EU will partner with the European pharmaceutical industry to finance 215 million euros in research projects to fight Ebola, mainly to develop vaccines and diagnostic tests, it announced Friday.
Jan 16, 2015
0
7
Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well ...
Dec 8, 2014
0
0
The World Health Organization voiced hope Tuesday the number of Ebola cases would start falling sharply early next year, stressing the need to develop rapid diagnostic tests for the end-phase.
Nov 18, 2014
0
0
A new test will accelerate global progress toward eliminating onchocerciasis, a leading cause of preventable blindness in Africa. PATH, an international nonprofit health organization, today announced the availability of the ...
Nov 3, 2014
0
0
People hospitalised with fever in Africa are most likely to be treated for malaria but, in some areas, nearly all of these patients are ill from a different infection, a new collaborative study led by a University of Otago ...
Jul 19, 2013
0
0
ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (NSCLC). It defines a distinct molecular subset of NSCLC, in particular adenocarcinoma ...
Jun 25, 2013
0
0
